3 ms·
Are studies like this that make me loose respect for a part of the Medical community the CDC included. In the last few hours of course this study is already bei
by belter 5y ago
Are studies like this that make me loose respect for a part of the Medical community the CDC included. In the last few hours of course this study is already being quoted in the media.
The conclusions:
Vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%).
The critical point here folks, is "during March 11–August 15"
Their conclusion...
===========================================================
"What are the implications for public health practice?
"Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized COVID-19 vaccines provide substantial protection against COVID-19 hospitalization."
===========================================================
Part they forgot to mention...."during March 11–August 15"...
Also...They are measuring Vaccine Effectiveness not Efficacy
"How do vaccine effectiveness studies differ from vaccine efficacy studies?"
https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm https://www.cdc.gov/flu/vaccines-work/effectivenessqa.htm
And one of the critical differences is:
"Vaccine effectiveness studies include people with underlying medical conditions who have been administered vaccines by different health care providers. Vaccine effectiveness studies can be used to determine if higher risk groups of people (often excluded from clinical trials/RCTs) respond differently to the vaccine."
From the study they got 5484 and excluded 1786 patients for
having immunocompromising conditions. Fine but that is about 32% of their universe...
Please remind me when and where these 32% of a certain population has been allowed to be excluded from current vaccine mandates?
- tinus_hn 5y agoIf immunocompromized people were in the study obviously the results would be even worse, but you’d be happy because you could dismiss it because it includes all these immunocompromized people tainting the results. You just don’t like the results because they don’t fit your ‘if everyone was vaccinated the pandemic would magically disappear’ religion.
- ramblerman 5y agoI don't really understand any of your objections. > Also...They are measuring Vaccine Effectiveness not Efficacy Effectiveness is what we care about, i.e. real world results. Unless you have some evidence to believe that the distribution chains between the vaccine providers were so imbalanced that one got tainted more than the rest. And if that's the case it would still make the result useful to decide which vaccine you want. > during March 11–August 15 (mentioned twice) Any study is going to be bound within a period of time. What makes you think this period was so special it would not be effective to present a comparison between the vaccines?
- pbaka 5y agoIf I understood OC correctly, and from my own understanding of statitics : An arbitrary 30% exclusion rate precludes the effectiveness study from giving any useful information either way : 30% is much larger than a 95% CI. As such, that resulting numbers have no teleological value. A decision can't be made either way. > What makes you think this period was so special it would not be effective to present a comparison between the vaccines? TLDR : it says nothing because too many things varied during that interval which are interdependent time-wise. The starting assumptions are not valid at the end. This is whay the israelis only study short windows of time. ---- Discussion: The study covers only the US during the selected period. The vaccination rates varied , from 25% to 50% (https://usafacts.org/visualizations/covid-vaccine-tracker-states/ https://usafacts.org/visualizations/covid-vaccine-tracker-st...). Delta variant was at less than 20% early june, it is 100% now (https://covid.cdc.gov/covid-data-tracker/#variant-proportions https://covid.cdc.gov/covid-data-tracker/#variant-proportion...). If you are going by the latest numbers from Israel (https://www.medrxiv.org/content/10.1101/2021.08.24.21262423v1 https://www.medrxiv.org/content/10.1101/2021.08.24.21262423v...) which leads US and UK by two months in regards to the Delta variant, effectiveness drops dramatically for delta (~65% for avg. hospitalization endpoint, 42% for infection endpoint in men, 53% for women). Vaccinated people can be infected and retransmit the virus five times more. The Delta has a R0 value (numb. of people a sick person infects) of 6 to 9 regardless of vaccinal status (depending on the study), whereas the other variants had a R0 value with the vaccine which dropped to 1,2-1,6. One is highly exponential in all cases, the other far from quadratic with proper protective measures. Antibody Ct dissapears after six months, also according to the latest Israeli numbers (https://www.medrxiv.org/content/10.1101/2021.08.29.21262798v1 https://www.medrxiv.org/content/10.1101/2021.08.29.21262798v...). Consequently, the study treats the data as an ergodic process, whereas it is clearly non-ergodic : - transmissions can be represented as a graph - previous situation influences future situation depending on varying antibody titers - vaccination occurence itself changes the opportunity for transmission - transmission of different variants depends on encountering differing vaccinal statuses, at different times In conclusion, all the relevant variables have varied too much, and the basic mathematical pressupposition is wrong, whereas the study treats it mathematically as a snapshot uin time. It is completely wrong because of the underlying data: Vaccination rate changes dramatically, in relation to the most prevalent variant at any given time, with an immune response to each variant is extremely different, a different points in time for each vaccine, which itself drops over time. Add to that the above-mentionned exclusion of 30% of the measured population... The israelis on the other hand study shorter 1-2 month windows. It is also far from perfect, but a much closer to a snapshot, so you can disregard the nature of the process which is measured and some notable value remains in regards to making a decision.